Ensuring optimal adherence to BCR-ABL1 tyrosine kinase inhibitor therapy for chronic myeloid leukemiaJuly 2, 2013Leukemia, Myelodysplasia, Transplantation
Biomarkers of small intestinal mucosal damage induced by chemotherapy: an emerging role for the 13C sucrose breath testMay 28, 2013Patient & Survivor Care
Predicting life expectancy in patients with advanced incurable cancer: a reviewMay 24, 2013Patient & Survivor Care
Resistance exercise interventions during and following cancer treatment: a systematic reviewMay 22, 2013Patient & Survivor CareBreast Cancer
Initiating palliative care conversations: lessons from Jewish bioethicsMarch 1, 2013Lung CancerPatient & Survivor Care
Twelve Reasons for Considering Buprenorphine as a Frontline Analgesic in the Management of PainNovember 13, 2012Patient & Survivor Care
Dasatinib in the first-line treatment of chronic myeloid leukemiaNovember 1, 2012Leukemia, Myelodysplasia, Transplantation
Management of dermatological toxicities in patients receiving EGFR inhibitorsOctober 1, 2012Patient & Survivor Care
